Profile photo Joost van Rosmalen

Joost van Rosmalen

Associate Professor

Strategic program(s):

Biography

Joost van Rosmalen is a biostatistician and clinical trial methodologist at Julius Center for Health Sciences and Primary Care of UMC Utrecht. His research is focused on the development and application of innovative methods for clinical trials, such as Bayesian adaptive trials, platform trials and trials that incorporate external information. The main area of application for these methods is in infection and immunity.

Research groups

Methods for AI and data science

Research aim

To develop and validate methods for data science, AI, statistics and causal inference and to improve medical research and patient care through impactful applications and collaborations.

Go to group

Clinical trial methodology & statistical consultation

Research aim

We develop, evaluate, and apply innovative clinical trial designs and sound statistical methodology to efficiently obtain high-quality evidence on healthcare interventions, ultimately optimizing patient outcomes

Go to group

Recent publications

Quality of Life in Patients with Locally Advanced Pancreatic Cancer During Stereotactic Radiotherapy Combined with Heat-Killed Mycobacterium Obuense Vaccination Laura Schafthuizen, Freek R van 't Land, Monique van Dijk, Miranda Moskie, Joost van Rosmalen, Casper H J van Eijck
Journal of palliative medicine, 2025, vol. 28, p.351-357
ASO Author Reflections Pieter Westenend, Claudia Meurs, Sara van Bekkum, Joost van Rosmalen, Marian Menke-Pluijmers, Sabine Siesling
Annals of surgical oncology, 2024, vol. 31, p.2272-2273
BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients Camille Kockerols, Peter J M Valk, Stéphanie Dulucq, Franck-Emmanuel Nicolini, François-Xavier Mahon, Ehab Atallah, Michael J Mauro, Jerald P Radich, Simona Bernardi, Domenico Russo, Mirko Farina, Silvia Mori, Carlo Gambacorti-Passerini, Ivan Civettini, Liu Lu, David Yeung, Susan Branford, Gioia Colafigli, Massimo Breccia, Pauline Hogenbirk, Joost van Rosmalen, Jan J Cornelissen, Peter E Westerweel
American journal of hematology, 2024, vol. 99, p.1632-1635
Reasons Patients With Primary Progressive Multiple Sclerosis Contact Their Specialist Nurses Rosaline van den Berg, Katelijn Blok, Nura Tebayna, Monique van Dijk, Joost van Rosmalen, Janet de Beukelaar
International Journal of MS Care, 2024, vol. 26, p.30-35
Bayesian interim analysis for prospective randomized studies Niek G van der Maas, Jurjen Versluis, Kazem Nasserinejad, Joost van Rosmalen, Thomas Pabst, Johan Maertens, Dimitri Breems, Markus Manz, Jacqueline Cloos, Gert J Ossenkoppele, Yngvar Floisand, Patrycja Gradowska, Bob Löwenberg, Gerwin Huls, Douwe Postmus, Francesco Pignatti, Jan J Cornelissen
Blood cancer journal, 2024, vol. 14
Minimally invasive surgical approach in children treated for oesophageal atresia is associated with attention problems at school age Anne-Fleur R L van Hal, John Vlot, Joost van Rosmalen, René M H Wijnen, Annabel P J M van Gils-Frijters, Saskia J Gischler, Lonneke M Staals, Hanneke IJsselstijn, André B Rietman
European Journal of Pediatrics, 2024, vol. 183, p.2131-2140